Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Cidara's antimicrobial reunion

Seasoned antiinfectives team at Cidara aiming to disrupt antifungal market

July 14, 2014 7:00 AM UTC

Investors in Cidara Therapeutics Inc.'s $32 million series A round are hoping for a repeat performance by a management team with a track record of exits in the infectious disease space.

5AM Ventures led the round and was joined by Aisling Capital, Frazier Healthcare and InterWest Partners...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article